Associated Papers
Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.
Weren RD et al.
Human Mutation, 2017
27767231 (PubMed )
Supplement: HUMU-38-226-s002.xlsx › SupplementaryTable2
A recessive variant of XRCC4 predisposes to non- BRCA1/2 breast cancer in chinese women and impairs the DNA damage response via dysregulated nuclear localization.
He M et al.
Oncotarget, 2014
25360583 (PubMed )
Supplement: oncotarget-05-12218-s001.pdf
Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients.
Lee E et al.
Breast Cancer Research : Bcr, 2008
18284688 (PubMed )
Supplement: bcr1865-S3.doc
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene.
Wijker M et al.
European Journal of Human Genetics : Ejhg, 1999
Select a paper to view details